DSM acquires Microbia
This article was originally published in The Tan Sheet
Executive Summary
Royal DSM will expand its natural carotenoids business by incorporating Microbia's proprietary platform and research and development capabilities. The Netherlands chemicals giant acquired Lexington, Mass.-based Microbia from Ironwood Pharmaceuticals under undisclosed terms, according to a Sept. 22 release. Microbia developed a technology platform that enables the production of natural carotenoids - including carotene and canthaxanthin - nutritional products and other specialty materials and chemicals from renewable resources
Royal DSM will expand its natural carotenoids business by incorporating Microbia's proprietary platform and research and development capabilities. The Netherlands chemicals giant acquired Lexington, Mass.-based Microbia from Ironwood Pharmaceuticals under undisclosed terms, according to a Sept. 22 release. Microbia developed a technology platform that enables the production of natural carotenoids - including carotene and canthaxanthin - nutritional products and other specialty materials and chemicals from renewable resources. |